BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18044703)

  • 1. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT; Longo K; Manfredi M; Lucetti C; Cossu G; Petrone A; Marconi R; Sensi M; Epifanio A; Eleopra R; Marchese R; Scaravilli T; Morgante L; Abbruzzese G; Bonuccelli U; Donati E; Pivonello R; Colao A; Barone P
    Mov Disord; 2008 Jan; 23(2):190-4. PubMed ID: 18044703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA; Kim BJ; Lee WY
    Mov Disord; 2002 Nov; 17(6):1242-7. PubMed ID: 12465063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
    Paviour DC; Thornton JS; Lees AJ; Jäger HR
    Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K; Zeng Y; Song C; Fu Y; Wan Q
    J Neurol; 2010 Sep; 257(9):1486-91. PubMed ID: 20405138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I; Gómez JC; Lezcano E; Aniel-Quiroga MA; Velasco F; Barcena J; Pérez Bas M; Hurtado P; Cruz Lachén M; Zarranz JJ
    Neurologia; 2006 Apr; 21(3):119-23. PubMed ID: 16575624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
    Pellecchia MT; Longo K; Pivonello R; Lucetti C; Marchese R; Spampani A; Manfredi M; Epifanio A; Sensi M; Scaravilli T; Bracco F; Eleopra R; Morgante L; Donati E; Marconi R; Abbruzzese G; Bonuccelli U; Zappia M; Colao A; Barone P
    Ann Neurol; 2006 Nov; 60(5):611-615. PubMed ID: 16958123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.
    Nicoletti G; Lodi R; Condino F; Tonon C; Fera F; Malucelli E; Manners D; Zappia M; Morgante L; Barone P; Barbiroli B; Quattrone A
    Brain; 2006 Oct; 129(Pt 10):2679-87. PubMed ID: 16815875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and reliable MRI diagnosis for progressive supranuclear palsy.
    Oba H; Yagishita A; Terada H; Barkovich AJ; Kutomi K; Yamauchi T; Furui S; Shimizu T; Uchigata M; Matsumura K; Sonoo M; Sakai M; Takada K; Harasawa A; Takeshita K; Kohtake H; Tanaka H; Suzuki S
    Neurology; 2005 Jun; 64(12):2050-5. PubMed ID: 15985570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.
    Linder J; Stenlund H; Forsgren L
    Mov Disord; 2010 Feb; 25(3):341-8. PubMed ID: 20108376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red flags for multiple system atrophy.
    Köllensperger M; Geser F; Seppi K; Stampfer-Kountchev M; Sawires M; Scherfler C; Boesch S; Mueller J; Koukouni V; Quinn N; Pellecchia MT; Barone P; Schimke N; Dodel R; Oertel W; Dupont E; Østergaard K; Daniels C; Deuschl G; Gurevich T; Giladi N; Coelho M; Sampaio C; Nilsson C; Widner H; Sorbo FD; Albanese A; Cardozo A; Tolosa E; Abele M; Klockgether T; Kamm C; Gasser T; Djaldetti R; Colosimo C; Meco G; Schrag A; Poewe W; Wenning GK;
    Mov Disord; 2008 Jun; 23(8):1093-9. PubMed ID: 18442131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes.
    Brettschneider J; Petzold A; Süssmuth SD; Landwehrmeyer GB; Ludolph AC; Kassubek J; Tumani H
    Mov Disord; 2006 Dec; 21(12):2224-7. PubMed ID: 17013909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease.
    Nicoletti G; Rizzo G; Barbagallo G; Tonon C; Condino F; Manners D; Messina D; Testa C; Arabia G; Gambardella A; Lodi R; Quattrone A
    Radiology; 2013 Jun; 267(3):843-50. PubMed ID: 23329659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S; Tings T; Helmschmied K; Neubert K; Wuttke W; Paulus W; Trenkwalder C
    Mov Disord; 2004 Dec; 19(12):1511-5. PubMed ID: 15390061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
    Rascol O; Sabatini U; Fabre N; Senard JM; Simonetta-Moreau M; Montastruc JL; Clanet M; Rascol A
    Mov Disord; 1995 Mar; 10(2):163-70. PubMed ID: 7753058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E; van't Hof M; Sweep F; Lenders JW; Oyen WJ; Horstink MW
    J Neurol; 2002 Sep; 249(9):1206-10. PubMed ID: 12242540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease.
    Schocke MF; Seppi K; Esterhammer R; Kremser C; Mair KJ; Czermak BV; Jaschke W; Poewe W; Wenning GK
    Neuroimage; 2004 Apr; 21(4):1443-51. PubMed ID: 15050569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain-to-pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy.
    Hussl A; Mahlknecht P; Scherfler C; Esterhammer R; Schocke M; Poewe W; Seppi K
    Mov Disord; 2010 Oct; 25(14):2444-9. PubMed ID: 20878992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.